Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine



Comments are closed.

Diamond Age Raises $50 Million Series A Round to Advance Robotic Home Construction System and Go To Market
Alzeca Biosciences Closes $11 Million Series A Financing
Atmosic Announces $72 Million in Additional Funding and Launches New Bluetooth® 5.3 SoC Family with Energy Harvesting Technology
Atomwise Raises $123 Million in Series B